Medartis Holding AG Reports Strong H1 Performance and Raises Full-Year Sales Guidance

In a remarkable display of resilience and strategic growth, Medartis Holding AG, a Swiss-based leader in health care equipment and supplies, has announced a robust 15.3% organic sales growth for the first half of 2025. This impressive performance has prompted the company to elevate its sales forecast for the entire year, signaling a positive outlook for stakeholders and the health care sector at large.

Operating primarily in the health care sector, Medartis specializes in the production of implants for the surgical fixation of bone fractures and osteotomies. The company’s diverse portfolio includes systems and medical instruments such as radius fixation, distal radius, arthrodesis systems, wrist and foot plates, and more. With a global customer base, Medartis continues to solidify its position as a key player in the health care equipment and supplies industry.

The company’s success in the first half of the year is attributed to significant growth in its EMEA (Europe, the Middle East, and Africa) and US markets. Despite facing challenges such as the appreciation of the Swiss Franc (CHF) and US tariffs, Medartis managed to sustain its core EBITDA margin at 17.8%. This financial resilience underscores the company’s robust operational strategies and its ability to navigate through economic headwinds.

A pivotal moment in Medartis’s recent achievements was the acquisition of the remaining 53% stake in KeriMedical in July. This strategic move is set to bolster Medartis’s product offerings, particularly with the planned US market entry of its flagship product, TOUCH. The integration of NeoOrtho, a business acquired in Brazil, is progressing as planned, with back-office consolidation and the establishment of a new production facility in Curitiba, further strengthening Medartis’s global footprint.

With a market capitalization of 1.02 billion CHF and trading on the SIX Swiss Exchange, Medartis’s performance in the first half of 2025 is a testament to its strategic vision and operational excellence. The company’s ability to deliver strong organic growth, coupled with strategic acquisitions and market expansions, positions it well for continued success in the dynamic health care sector.

As Medartis looks ahead, the company remains focused on innovation, strategic growth, and delivering value to its customers and stakeholders. With a solid foundation and a clear strategic direction, Medartis is well-equipped to navigate the challenges and opportunities that lie ahead in the health care industry.